Stock

Innoviva, Inc. INVA

$21.43+1.08%

All stocks Create account to unlock

Overview

INVA market data

Price History

INVA price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for INVA. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

5 captured

Nortiva Bio Launches Clinical-Stage Biopharmaceutical Company To Develop Long-Acting Oral Medicines · Jun 18, 2026, 12:15 PM

Innoviva Specialty Therapeutics Inks Agreement With Dr. Reddy's Laboratories To Develop, Commercialize XACDURO To Treat Bacterial Pneumonia · Jun 16, 2026, 12:10 PM

HC Wainwright & Co. Reiterates Buy on Innoviva, Maintains $46 Price Target · Jun 1, 2026, 10:58 AM

BTIG Reiterates Buy on Innoviva, Maintains $42 Price Target · May 26, 2026, 11:08 AM

8-K filing — Innoviva, Inc. (INVA) · May 18, 2026, 8:21 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock